돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 220494생성일: 2026년 10월 25일

1-Methyl-1H-pyrazole-4-carbaldehyde → 3'-Chloro-4-(1-methyl-1H-pyrazol-4-ylmethyl)-3,4,5,6-tetrahydro-2H-[1,2']bipyrazine

https://huagongshe.com/reaction/220494

반응식

참여 물질

역할이름HCID투입량
반응물1-Methyl-1H-pyrazole-4-carbaldehydeHCID 573117—
반응물Sodium triacetoxyborohydrideHCID 5049666—
반응물2-Chloro-3-(piperazin-1-yl)pyrazineHCID 14086438—
용매TetrahydrofuranHCID 8028—
생성물3'-Chloro-4-(1-methyl-1H-pyrazol-4-ylmethyl)-3,4,5,6-tetrahydro-2H-[1,2']bipyrazineHCID 86641657—

반응 단계

Dissolve 3′-chloro-3,4,5,6-tetrahydro-2H-[1,2′]bipyrazinyl (3.43 g, 17.3 mmol) in tetrahydrofuran (100 mL). Add 1-methyl-1H-pyrazole-4-carbaldehyde (2.244 g, 20.38 mmol) in dry tetrahydrofuran (5 mL), stir for 10 min. at room temperature, add sodium triacetoxyborohydride (4.32 g, 20.4 mmol) and subject the reaction to ultrasound stirring for 6 hr. at room temperature. Add saturated aqueous sodium hydrogen carbonate (100 mL) then 2 N sodium hydroxide (10 mL) to the mixture and extract with DCM (2×200 mL). Pass the combined DCM extracts through an IST Phase Separator Frit®, concentrate and purify (silica gel chromatography, eluting with 0:100 to 8:92 methanol:DCM), to give the title preparation as a crystalline solid (5.21 g, 92%). MS (ES): m/z=293.1 [M+H]+.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08202873B2
출처 데이터셋uspto-grants-2012_06
ORD IDord-cf81399f6b664e0cbccab945fd1dbf2c
출처 메모uspto-grants-2012_06